Enzeevu (aflibercept-abzv), a biosimilar developed by Sandoz, demonstrated biosimilarity to reference aflibercept (Eylea) in ...
The 5 products are 1-5: Yesafili (aflibercept-jbvf) in May 2024 Opuviz (aflibercept-yszy) in May 2024 Ahzantive (aflibercept-mrbb) in July 2024 Enzeevu (aflibercept-abzv) in August 2024 Pavblu ...
MEDIA RELEASE Strong first year as standalone company; global leader Sandoz uniquely positioned in attractive and growing USD 200 billion market for generics and biosimilarsLeading in home market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback